How much funding has Singular Genomics raised?

Singular Genomics has raised $104.0M in total funding, most recently a Venture Round.

Who are Singular Genomics's investors?

Singular Genomics's investors include Deerfield Management, J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, Legend Capital.

When was Singular Genomics founded?

Singular Genomics was founded in 2016.

Where is Singular Genomics headquartered?

Singular Genomics is headquartered in La Jolla, California, United States.

What industry is Singular Genomics in?

Singular Genomics operates in Genomics, Life Sciences.

How many employees does Singular Genomics have?

Singular Genomics has 201-500 employees.

Singular Genomics

Acquired

G4X Spatial Technology

La Jolla, United States · Founded 2016 · $104.0M raised

Genomics

Life Sciences

Headquarters: La Jolla, California
Employees: 201–500
Founded: 2016
Business Model: B2B

Website: singulargenomics.com
Total Funding: $104.0M
Last Round: $104.0M Venture RoundFeb 2021
Rounds: 3

About

Singular Genomics is inventing at the forefront of genomics with its commercially available G4 Sequencing Platform and G4X Spatial Technology. The company serves research and clinical translational laboratories with high-throughput spatial multiomics sequencing, enabling precise cell-level analysis in complex tissues.

Summary

Singular Genomics is a Genomics company based in La Jolla, United States, founded in 2016. It has raised $104.0M in total across 3 rounds, most recently a $104.0M Venture Round round in Feb 2021. Investors include Deerfield Management, J.P. Morgan and Goldman Sachs.

LinkedIn X (Twitter)